Signature Biologics, LLC – FDA 483, Dec 16, 2021
An FDA inspection of Signature Biologics, LLC in Irving, TX, revealed significant deficiencies in the manufacturing of its injectable umbilical cord tissue and amniotic membrane derived products. The firm failed to adequately validate aseptic processes, perform endotoxin testing, investigate sterility failures, and establish proper production and process controls for its purported sterile drug products and HCT/Ps. These issues indicate a severe lack of quality control and process validation, potentially compromising product sterility and safety.
ID · 46de8b42-ff0a-45b1-a19a-ddcee1662ecf
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.